PURR
Hyperliquid Strategies Inc Common StockNASDAQFINANCIAL SERVICESCAPITAL MARKETS
Key Statistics
Market Cap
$1.03B
P/E Ratio
—
EPS
—
Beta
—
52W High
$8.79
52W Low
$3.01
50-Day MA
$6.10
200-Day MA
$4.91
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Hyperliquid Strategies Inc Common Stock
Hyperliquid Strategies Inc., through its subsidiary, is a a biotechnology company that owns a platform for biologic medicines of single or bifunctional action. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 7381.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $4.75 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $134.62M |
| Float | 0 |
| % Insiders | 1.95% |
| % Institutions | 32.08% |
Historical Volatility
HV 10-Day
125.19%
HV 20-Day
96.13%
HV 30-Day
92.15%
HV 60-Day
107.80%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($9.58 target)
1
Strong Buy2
BuyMore FINANCIAL SERVICES Stocks
Data last updated: 5/25/2026